An Ideal Prognostic Test for Estrogen Receptor–Positive Breast Cancer?-Reference-Cited by-同舟云学术

An Ideal Prognostic Test for Estrogen Receptor–Positive Breast Cancer?

Published:2008-09-01 Issue:25 Volume:26 Page:4058-4059
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Paik Soonmyung¹,Tang Gong²,Fumagalli Debora¹

Affiliation:

1. Division of Pathology, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA

2. the Biostatistics Center, National Surgical Adjuvant Breast and Bowel Project and Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.16.7528

Reference12 articles.

1. Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer

2. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

3. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

4. Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

5. Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RecurIndex-Guided postoperative radiotherapy with or without Avoidance of Irradiation of regional Nodes in 1–3 node-positive breast cancer (RIGAIN): a study protocol for a multicentre, open-label, randomised controlled prospective, phase III trial;BMJ Open;2024-07

2. Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast Cancer;JCO Precision Oncology;2024-07

3. Is the percentage of hormone receptor positivity in HR+ HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic?;Frontiers in Oncology;2024-06-18

4. Genomic Testing to Guide Local Therapy Decisions in Hormone Receptor-Positive Breast Cancer;Current Breast Cancer Reports;2024-03-07

5. MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival;BMC Cancer;2024-03-04